Jean-Bernard Tanqueray

Moleac Pte Ltd. develops and distributes biopharmaceutical products. It operates as a bio-pharmaceutical company that develops new medicines for the unmet needs of patients suffering from neurological, cardio-vascular and aging conditions. The firm's flagship product NeuroAiD, helps patients recover faster and better from stroke disabilities. The company was founded by David Picard and Marc Vasseur in 2003 and is headquartered in Singapore.

FORMAC Pharmaceuticals NV engages in drug delivery and development services. The firm applies its silica based drug delivery platforms for improving in vivo performance of poorly soluble compounds. The company was founded by Johan A. Martens, Paul Joseph Rutgeerts, Guy Van den Mooter and Jan Baptist Van Humbeeck in 2007 and is headquartered in Heverlee, Belgium.

Hunza Management SARL is a private equity firm headquartered in Luxembourg. The current firm was established in 1998 to manage Hunza Ventures, the venture capital investment vehicle of the family of the retired Belgian entrepreneur Guy Ullens. Baron Guy Ullens de Schooten and the Wittouck family built up and controlled the diversified European food manufacturing group Artal, based in Luxembourg and historically focused on the Belgian sugar industry.

Arbion Ltd. is a wealth management firm headquartered in London, UK. Formerly known as Signia Wealth Ltd., the firm was founded by Gautam Batra and Nathalie Dauriac-Stoebe in 2009 as True Wealth Ltd. They are a subsidiary of Arbion Holdings Ltd. Arbion targets the ultra-high net worth market and was formed to provide a full wealth and investment management service to private individuals, their families and institutional clients.

iTeos Therapeutics SA engages in the discovery of immunomodulators for cancer therapy. It operates as a biotechnology company which focuses on targeting metabolism of the tumor microenvironment through development of small-molecule immunomodulators for cancer treatment. The firm develops small molecules designed to target the tumor microenvironment by inhibiting cancer-induced immune suppression. Targeting such resistance mechanisms will enhance the clinical efficacy of both standards of care treatments as well as the newer immunomodulatory therapies based on the blockade of immune checkpoints. The company was founded in 2011 by Michel Detheux and Benoit Van den Eynde and is headquartered in Gosselies, Belgium.

App-UX Ltd. develops and offers droplet computing which is a thin and lightweight compatibility layer which enables windows PC applications. The company was founded on September 22, 2014 and is headquartered in Kidderminster, the United Kingdom.

Ben Uri Gallery & Museum Ltd. is a British company that operates historical sites and buildings. The private company is based in London, UK and was founded in 1980.